{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T23:47:02Z","timestamp":1791935222088,"version":"4.3.4"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Thrombosis J"],"DOI":"10.1186\/s12959-026-00936-8","type":"journal-article","created":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:39:58Z","timestamp":1791920398000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Anticoagulation-associated hemorrhage in atrial fibrillation as a marker of occult malignancy: a narrative review"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-1090-8651","authenticated-orcid":false,"given":"Arisha","family":"Masood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6532-4047","authenticated-orcid":false,"given":"Zobia","family":"Aamir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6673-2028","authenticated-orcid":false,"given":"Aaminah","family":"Khurram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1921-5039","authenticated-orcid":false,"given":"Hira","family":"Tariq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1541-3037","authenticated-orcid":false,"given":"Ayesha","family":"Shaukat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5509-7137","authenticated-orcid":false,"given":"Azka","family":"Mujeeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9393-1215","authenticated-orcid":false,"given":"Aymar","family":"Akilimali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,13]]},"reference":[{"key":"936_CR1","doi-asserted-by":"publisher","unstructured":"Lane DA, Skj\u00f8th F, Lip GYH, Larsen TB, Kotecha D. Temporal trends in incidence, prevalence, and mortality of atrial fibrillation in primary care. J Am Heart Assoc. 2017;6(5). https:\/\/doi.org\/10.1161\/JAHA.116.005155.","DOI":"10.1161\/JAHA.116.005155"},{"key":"936_CR2","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.blre.2019.03.005","volume":"35","author":"G Chu","year":"2019","unstructured":"Chu G, Versteeg HH, Verschoor AJ, Trines SA, Hemels MEW, Ay C, et al. Atrial fibrillation and cancer \u2013 An unexplored field in cardiovascular oncology. Blood Rev. 2019;35:59\u201367. https:\/\/doi.org\/10.1016\/j.blre.2019.03.005.","journal-title":"Blood Rev"},{"issue":"24","key":"936_CR3","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1161\/CIRCULATIONAHA.120.049768","volume":"142","author":"AH Katsanos","year":"2020","unstructured":"Katsanos AH, Kamel H, Healey JS, Hart RG. Stroke Prevention in Atrial Fibrillation. Circulation. 2020;142(24):2371\u201388. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.049768.","journal-title":"Circulation"},{"issue":"5","key":"936_CR4","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.hjc.2020.11.007","volume":"62","author":"A Papanastasiou","year":"2021","unstructured":"Papanastasiou A, Morsi-Yeroyannis A, Karagiannidis E, Kartas A, Doundoulakis I, Karvounis H, et al. Association of anticoagulant-related bleeding events with cancer detection in atrial fibrillation: A systematic review and meta-analysis. Hellenic J Cardiol. 2021;62(5):359\u201365. https:\/\/doi.org\/10.1016\/j.hjc.2020.11.007.","journal-title":"Hellenic J Cardiol"},{"issue":"11","key":"936_CR5","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1161\/CIRCULATIONAHA.124.070865","volume":"151","author":"K Grewal","year":"2025","unstructured":"Grewal K, Wang X, Austin PC, Jackevicius CA, Nardi-Agmon I, Ko DT, et al. Bleeding and New Malignancy Diagnoses After Anticoagulation for Atrial Fibrillation: A Population-Based Cohort Study. Circulation. 2025;151(11):773\u201382. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.124.070865.","journal-title":"Circulation"},{"issue":"4","key":"936_CR6","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3892\/ol.2022.13244","volume":"23","author":"D Farmakis","year":"2022","unstructured":"Farmakis D, Papakotoulas P, Angelopoulou E, Bischiniotis T, Giannakoulas G, Kliridis P, et al. Anticoagulation for atrial fibrillation in active cancer (Review). Oncol Lett. 2022;23(4):124. https:\/\/doi.org\/10.3892\/ol.2022.13244.","journal-title":"Oncol Lett"},{"issue":"2","key":"936_CR7","doi-asserted-by":"publisher","first-page":"265","DOI":"10.21037\/apm.2017.11.01","volume":"7","author":"C Johnstone","year":"2018","unstructured":"Johnstone C, Rich SE. Bleeding in cancer patients and its treatment: a review. Ann Palliat Med. 2018;7(2):265\u201373. https:\/\/doi.org\/10.21037\/apm.2017.11.01.","journal-title":"Ann Palliat Med"},{"issue":"1","key":"936_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12307-012-0102-2","volume":"6","author":"KD Barlow","year":"2013","unstructured":"Barlow KD, Sanders AM, Soker S, Ergun S, Metheny-Barlow LJ. Pericytes on the Tumor Vasculature: Jekyll or Hyde? Cancer Microenvironment. 2013;6(1):1\u201317. https:\/\/doi.org\/10.1007\/s12307-012-0102-2.","journal-title":"Cancer Microenvironment"},{"issue":"11","key":"936_CR9","doi-asserted-by":"publisher","first-page":"e2061","DOI":"10.1002\/onco.13897","volume":"26","author":"A Sivakumar","year":"2021","unstructured":"Sivakumar A, Caulfield SE, Zhang C, Goyal S, Bilen MA, Beardslee TJ. Retrospective Study of Bleeding Risk with Concomitant Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor and Anticoagulation. Oncologist. 2021;26(11):e2061\u20139. https:\/\/doi.org\/10.1002\/onco.13897.","journal-title":"Oncologist"},{"issue":"17","key":"936_CR10","doi-asserted-by":"publisher","first-page":"3078","DOI":"10.1200\/JCO.2000.18.17.3078","volume":"18","author":"BA Hutten","year":"2000","unstructured":"Hutten BA, Prins MH, Gent M, Ginsberg J, Tijssen JGP, B\u00fcller HR. Incidence of Recurrent Thromboembolic and Bleeding Complications Among Patients With Venous Thromboembolism in Relation to Both Malignancy and Achieved International Normalized Ratio: A Retrospective Analysis. J Clin Oncol. 2000;18(17):3078\u201383. https:\/\/doi.org\/10.1200\/JCO.2000.18.17.3078.","journal-title":"J Clin Oncol"},{"issue":"10","key":"936_CR11","doi-asserted-by":"publisher","first-page":"8547","DOI":"10.1007\/s00520-022-07136-w","volume":"30","author":"A Escobar","year":"2022","unstructured":"Escobar A, Salem AM, Dickson K, Johnson TN, Burk KJ, Bashoura L, et al. Anticoagulation and bleeding in the cancer patient. Support Care Cancer. 2022;30(10):8547\u201357. https:\/\/doi.org\/10.1007\/s00520-022-07136-w.","journal-title":"Support Care Cancer"},{"key":"936_CR12","doi-asserted-by":"publisher","unstructured":"Raposeiras-Roub\u00edn S, Abu Assi E, Barreiro Pardal C, Cesp\u00f3n Fern\u00e1ndez M, Mu\u00f1oz Pousa I, Cobas Paz R, et al. New cancer diagnosis after bleeding in anticoagulated patients with atrial fibrillation. J Am Heart Assoc. 2020;9(22). https:\/\/doi.org\/10.1161\/JAHA.120.016836.","DOI":"10.1161\/JAHA.120.016836"},{"key":"936_CR13","doi-asserted-by":"publisher","unstructured":"Mehta HB, An H, Ardeshirrouhanifard S, Raji MA, Alexander GC, Segal JB. Comparative effectiveness and safety of direct oral anticoagulants versus warfarin among adults with cancer and atrial fibrillation. Circ Cardiovasc Qual Outcomes. 2022;15(12). https:\/\/doi.org\/10.1161\/CIRCOUTCOMES.122.008951.","DOI":"10.1161\/CIRCOUTCOMES.122.008951"},{"issue":"4","key":"936_CR14","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s10557-024-07589-7","volume":"39","author":"B Truong","year":"2025","unstructured":"Truong B, Hornsby L, Fox B, Chou C, Zheng J, Qian J. Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients with Atrial Fibrillation and Cancer: A Target Trial Emulation from SEER-Medicare Database. Cardiovasc Drugs Ther. 2025;39(4):823\u201335. https:\/\/doi.org\/10.1007\/s10557-024-07589-7.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"5","key":"936_CR15","doi-asserted-by":"publisher","first-page":"oeae081","DOI":"10.1093\/ehjopen\/oeae081","volume":"4","author":"K Proesmans","year":"2024","unstructured":"Proesmans K, Grymonprez M, Rottey S, Lahousse L. Anticoagulant-related bleeding as a sign of underlying tumoural lesions in patients with atrial fibrillation: a nationwide cohort study. Eur heart J open. 2024;4(5):oeae081.","journal-title":"Eur heart J open"},{"issue":"13","key":"936_CR16","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/S0735-1097(24)02028-X","volume":"83","author":"K Grewal","year":"2024","unstructured":"Grewal K, Wang X, Dorian P, Austin P, Jackevicius C, Ko DT, THE ASSOCIATION OF BLEEDING AFTER ANTICOAGULATION FOR ATRIAL FIBRILLATION WITH NEW MALIGNANCY DIAGNOSES, et al. J Am Coll Cardiol. 2024;83(13):38. https:\/\/doi.org\/10.1016\/S0735-1097(24)02028-X.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"936_CR17","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1093\/eurheartj\/ehz964","volume":"43","author":"PV Rasmussen","year":"2022","unstructured":"Rasmussen PV, Dalgaard F, Gislason GH, Brandes A, Johnsen SP, Grove EL, et al. Gastrointestinal bleeding and the risk of colorectal cancer in anticoagulated patients with atrial fibrillation. Eur Heart J. 2022;43(7):e38\u201344. https:\/\/doi.org\/10.1093\/eurheartj\/ehz964.","journal-title":"Eur Heart J"},{"issue":"1","key":"936_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2217\/fca-2017-0063","volume":"14","author":"H Koike","year":"2018","unstructured":"Koike H, Fujino T, Koike M, Yao S, Akitsu K, Shinohara M, et al. Bleeding With Oral Anticoagulant Dabigatran is Highly Associated With Occult Cancers in Atrial Fibrillation Patients. Future Cardiol. 2018;14(1):27\u201336. https:\/\/doi.org\/10.2217\/fca-2017-0063.","journal-title":"Future Cardiol"},{"issue":"6","key":"936_CR19","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s40256-024-00676-y","volume":"24","author":"F Angeli","year":"2024","unstructured":"Angeli F, Bergamaschi L, Armillotta M, Sansonetti A, Stefanizzi A, Canton L, et al. Impact of Newly Diagnosed Cancer on Bleeding Events in Patients with Atrial Fibrillation Treated with Direct Oral Anticoagulants. Am J Cardiovasc Drugs. 2024;24(6):813\u201321. https:\/\/doi.org\/10.1007\/s40256-024-00676-y.","journal-title":"Am J Cardiovasc Drugs"},{"key":"936_CR20","doi-asserted-by":"publisher","unstructured":"Riva L, Di Pasquale G. Identificazione precoce di cancro dopo sanguinamento in corso di terapia anticoagulante orale nei pazienti con fibrillazione atriale: una nuova prospettiva. G Ital Cardiol. 2022;23(2). https:\/\/doi.org\/10.1714\/3735.37213.","DOI":"10.1714\/3735.37213"},{"issue":"2","key":"936_CR21","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3390\/epidemiologia4020012","volume":"4","author":"S Tancredi","year":"2023","unstructured":"Tancredi S, Cullati S, Chiolero A. Screening and surveillance bias in cancer. Epidemiologia. 2023;4(2):117\u201320.","journal-title":"Epidemiologia"},{"issue":"1","key":"936_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40471-013-0004-y","volume":"1","author":"KS Joseph","year":"2014","unstructured":"Joseph KS, Mehrabadi A, Lisonkova S. Confounding by indication and related concepts. Curr Epidemiol Rep. 2014;1(1):1\u20138.","journal-title":"Curr Epidemiol Rep"},{"issue":"5","key":"936_CR23","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1634\/theoncologist.9-5-561","volume":"9","author":"J Pereira","year":"2004","unstructured":"Pereira J, Phan T. Management of Bleeding in Patients with Advanced Cancer. Oncologist. 2004;9(5):561\u201370. https:\/\/doi.org\/10.1634\/theoncologist.9-5-561.","journal-title":"Oncologist"},{"key":"936_CR24","doi-asserted-by":"publisher","unstructured":"Wang MX, Guccione J, Korivi BR, Abdelsalam ME, Klimkowski SP, Soliman M, et al. Gastrointestinal bleeding: imaging and interventions in cancer patients. Br J Radiol. 2022;95(1135). https:\/\/doi.org\/10.1259\/bjr.20211158.","DOI":"10.1259\/bjr.20211158"},{"key":"936_CR25","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.ejim.2024.04.012","volume":"127","author":"Y Nishimoto","year":"2024","unstructured":"Nishimoto Y, Yamashita Y, Morimoto T, Chatani R, Kaneda K, Ikeda N, et al. Direct oral anticoagulant-associated bleeding complications in patients with gastrointestinal cancer and venous thromboembolism. Eur J Intern Med. 2024;127:74\u201383. https:\/\/doi.org\/10.1016\/j.ejim.2024.04.012.","journal-title":"Eur J Intern Med"},{"issue":"20","key":"936_CR26","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1200\/JCO.2018.78.8034","volume":"36","author":"AM Young","year":"2018","unstructured":"Young AM, Marshall A, Thirlwall J, Chapman O, Lokare A, Hill C, et al. Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D). J Clin Oncol. 2018;36(20):2017\u201323. https:\/\/doi.org\/10.1200\/JCO.2018.78.8034.","journal-title":"J Clin Oncol"},{"issue":"3","key":"936_CR27","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.jtha.2025.11.024","volume":"24","author":"N van Es","year":"2026","unstructured":"van Es N, Scheres LJJ, Sanfilippo KM, B\u00fcller H, Carrier M, Di Nisio M, et al. The win ratio for evaluating edoxaban vs dalteparin for cancer-associated venous thromboembolism: an analysis of the randomized Hokusai Venous Thromboembolism Cancer trial. J Thromb Haemost. 2026;24(3):1032\u201341. https:\/\/doi.org\/10.1016\/j.jtha.2025.11.024.","journal-title":"J Thromb Haemost"},{"issue":"7","key":"936_CR28","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1001\/jamainternmed.2016.0960","volume":"176","author":"M Bretthauer","year":"2016","unstructured":"Bretthauer M, Kaminski MF, L\u00f8berg M, Zauber AG, Regula J, Kuipers EJ, et al. Population-Based Colonoscopy Screening for Colorectal Cancer. JAMA Intern Med. 2016;176(7):894. https:\/\/doi.org\/10.1001\/jamainternmed.2016.0960.","journal-title":"JAMA Intern Med"},{"key":"936_CR29","doi-asserted-by":"publisher","unstructured":"Rodgers M, Nixon J, Hempel S, Aho T, Kelly J, Neal D, et al. Diagnostic tests and algorithms used in the investigation of haematuria: systematic reviews and economic evaluation. Health Technol Assess. 2006;10(18). https:\/\/doi.org\/10.3310\/hta10180.","DOI":"10.3310\/hta10180"},{"key":"936_CR30","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.urology.2016.09.018","volume":"100","author":"SA David","year":"2017","unstructured":"David SA, Patil D, Alemozaffar M, Issa MM, Master VA, Filson CP. Urologist Use of Cystoscopy for Patients Presenting With Hematuria in the United States. Urology. 2017;100:20\u20136. https:\/\/doi.org\/10.1016\/j.urology.2016.09.018.","journal-title":"Urology"},{"issue":"4","key":"936_CR31","doi-asserted-by":"publisher","first-page":"299","DOI":"10.5152\/dir.2014.13426","volume":"20","author":"AR Larici","year":"2014","unstructured":"Larici AR, Franchi P, Occhipinti M, Contegiacomo A, Ciello A, del, Calandriello L, et al. Diagnosis and management of hemoptysis. Diagn Interventional Radiol. 2014;20(4):299\u2013309. https:\/\/doi.org\/10.5152\/dir.2014.13426.","journal-title":"Diagn Interventional Radiol"},{"key":"936_CR32","unstructured":"Benjamin R, Karsonovich T. Intracerebral hemorrhagic stroke. 2026. PMID: 31971743."},{"key":"936_CR33","unstructured":"Mayo Clinic. Endoscopy [Internet]. Rochester (MN): Mayo Foundation for Medical Education and Research; [cited 2026 May 3]. Available from: https:\/\/www.mayoclinic.org\/tests-procedures\/endoscopy\/multimedia\/endoscopy\/img-20007299."},{"key":"936_CR34","unstructured":"Cleveland Clinic. Colonoscopy: what it is, procedure details, results [Internet]. Cleveland (OH): Cleveland Clinic; [cited 2026 May 3]. Available from: https:\/\/my.clevelandclinic.org\/health\/diagnostics\/4949-colonoscopy."},{"key":"936_CR35","unstructured":"National Cancer Institute. Definition of bronchoscopy [Internet]. Bethesda (MD): National Cancer Institute; [cited 2026 May 3]. Available from: https:\/\/www.cancer.gov\/publications\/dictionaries\/cancer-terms\/def\/bronchoscopy."},{"key":"936_CR36","unstructured":"Johns Hopkins ACG System. Risk stratification 101: what is it and how is it used? [Internet]. Baltimore (MD): Johns Hopkins University; [cited 2026 May 3]. Available from: https:\/\/www.hopkinsacg.org\/risk-stratification-101-what-is-it-and-how-is-it-used\/."},{"key":"936_CR37","unstructured":"Bladder and other urothelial cancers screening: patient version. 2002. PMID: 26389218."},{"issue":"5","key":"936_CR38","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/ajg.2016.155","volume":"111","author":"LL Strate","year":"2016","unstructured":"Strate LL, Gralnek IM. ACG Clinical Guideline: Management of Patients With Acute Lower Gastrointestinal Bleeding. Am J Gastroenterol. 2016;111(5):755. https:\/\/doi.org\/10.1038\/ajg.2016.155.","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"936_CR39","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1136\/gutjnl-2021-325184","volume":"70","author":"AM Veitch","year":"2021","unstructured":"Veitch AM, Radaelli F, Alikhan R, Dumonceau JM, Eaton D, Jerrome J, et al. Endoscopy in patients on antiplatelet or anticoagulant therapy: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guideline update. Gut. 2021;70(9):1611\u201328. https:\/\/doi.org\/10.1136\/gutjnl-2021-325184.","journal-title":"Gut"},{"issue":"6S","key":"936_CR40","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1016\/j.juro.2012.09.078","volume":"188","author":"R Davis","year":"2012","unstructured":"Davis R, Jones JS, Barocas DA, Castle EP, Lang EK, Leveillee RJ, et al. Diagnosis, Evaluation and Follow-Up of Asymptomatic Microhematuria (AMH) in Adults: AUA Guideline. J Urol. 2012;188(6S):2473\u201381. https:\/\/doi.org\/10.1016\/j.juro.2012.09.078.","journal-title":"J Urol"},{"issue":"5","key":"936_CR41","doi-asserted-by":"publisher","first-page":"S148","DOI":"10.1016\/j.jacr.2020.01.043","volume":"17","author":"KM Olsen","year":"2020","unstructured":"Olsen KM, Manouchehr-pour S, Donnelly EF, Henry TS, Berry MF, Boiselle PM, et al. ACR Appropriateness Criteria\u00ae Hemoptysis. J Am Coll Radiol. 2020;17(5):S148\u201359. https:\/\/doi.org\/10.1016\/j.jacr.2020.01.043.","journal-title":"J Am Coll Radiol"},{"issue":"19","key":"936_CR42","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1001\/jama.2021.6238","volume":"325","author":"KW Davidson","year":"2021","unstructured":"Davidson KW, Barry MJ, Mangione CM, Cabana M, Caughey AB, Davis EM, et al. Screen Colorectal Cancer JAMA. 2021;325(19):1965. https:\/\/doi.org\/10.1001\/jama.2021.6238.","journal-title":"Screen Colorectal Cancer JAMA"},{"issue":"18","key":"936_CR43","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1001\/jama.2018.3710","volume":"319","author":"DC Grossman","year":"2018","unstructured":"Grossman DC, Curry SJ, Owens DK, Bibbins-Domingo K, Caughey AB, Davidson KW, et al. Screening for Prostate Cancer. JAMA. 2018;319(18):1901. https:\/\/doi.org\/10.1001\/jama.2018.3710.","journal-title":"JAMA"},{"issue":"2","key":"936_CR44","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.juro.2013.04.119","volume":"190","author":"HB Carter","year":"2013","unstructured":"Carter HB, Albertsen PC, Barry MJ, Etzioni R, Freedland SJ, Greene KL, et al. Early Detection of Prostate Cancer: AUA Guideline. J Urol. 2013;190(2):419\u201326. https:\/\/doi.org\/10.1016\/j.juro.2013.04.119.","journal-title":"J Urol"},{"issue":"12","key":"936_CR45","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1001\/jamaoncol.2019.3616","volume":"5","author":"J Tie","year":"2019","unstructured":"Tie J, Cohen JD, Wang Y, Christie M, Simons K, Lee M, et al. Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer. JAMA Oncol. 2019;5(12):1710. https:\/\/doi.org\/10.1001\/jamaoncol.2019.3616.","journal-title":"JAMA Oncol"},{"key":"936_CR46","doi-asserted-by":"publisher","first-page":"106126","DOI":"10.1016\/j.compbiomed.2022.106126","volume":"150","author":"J Lu","year":"2022","unstructured":"Lu J, Hutchens R, Hung J, Bennamoun M, McQuillan B, Briffa T, et al. Performance of multilabel machine learning models and risk stratification schemas for predicting stroke and bleeding risk in patients with non-valvular atrial fibrillation. Comput Biol Med. 2022;150:106126. https:\/\/doi.org\/10.1016\/j.compbiomed.2022.106126. PubMed PMID: 36206696.","journal-title":"Comput Biol Med"},{"issue":"5","key":"936_CR47","doi-asserted-by":"publisher","first-page":"e136","DOI":"10.1002\/cai2","volume":"3","author":"A Ghasemi","year":"2024","unstructured":"Ghasemi A, Hashtarkhani S, Schwartz DL, Shaban-Nejad A. Explainable artificial intelligence in breast cancer detection and risk prediction: A systematic scoping review. Cancer Innov. 2024;3(5):e136. https:\/\/doi.org\/10.1002\/cai2. 136 PubMed PMID: 39430216.","journal-title":"Cancer Innov"},{"issue":"4","key":"936_CR48","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1007\/s12094-024-03586-2","volume":"27","author":"AJ Mu\u00f1oz Mart\u00edn","year":"2025","unstructured":"Mu\u00f1oz Mart\u00edn AJ, Lecumberri R, Souto JC, Obispo B, Sanchez A, Aparicio J, et al. Prediction model for major bleeding in anticoagulated patients with cancer-associated venous thromboembolism using machine learning and natural language processing. Clin Transl Oncol. 2025;27(4):1816\u201325. https:\/\/doi.org\/10.1007\/s12094-024-03586-2. PubMed PMID: 39276289.","journal-title":"Clin Transl Oncol"},{"issue":"4","key":"936_CR49","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1056\/NEJMoa2406674","volume":"392","author":"CT Ruff","year":"2025","unstructured":"Ruff CT, Patel SM, Giugliano RP, Morrow DA, Hug B, Kuder JF, et al. Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation. N Engl J Med. 2025;392(4):361\u201371. https:\/\/doi.org\/10.1056\/NEJMoa2406674.","journal-title":"N Engl J Med"},{"issue":"1","key":"936_CR50","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1056\/NEJMoa2407105","volume":"392","author":"JP Piccini","year":"2025","unstructured":"Piccini JP, Patel MR, Steffel J, Ferdinand K, Van Gelder IC, Russo AM, et al. Asundexian versus Apixaban in Patients with Atrial Fibrillation. N Engl J Med. 2025;392(1):23\u201332. https:\/\/doi.org\/10.1056\/NEJMoa2407105.","journal-title":"N Engl J Med"},{"key":"936_CR51","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.ahj.2024.08.011","volume":"277","author":"SS Jain","year":"2024","unstructured":"Jain SS, Mahaffey KW, Pieper KS, Shimizu W, Potpara T, Ruff CT, LIBREXIA AF Trial Investigators and Committees, et al. Milvexian vs apixaban for stroke prevention in atrial fibrillation: The LIBREXIA atrial fibrillation trial rationale and design. Am Heart J. 2024;277:145\u201358. https:\/\/doi.org\/10.1016\/j.ahj.2024.08.011.","journal-title":"Am Heart J"}],"container-title":["Thrombosis Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12959-026-00936-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12959-026-00936-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12959-026-00936-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T23:17:46Z","timestamp":1791933466000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12959-026-00936-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,13]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["936"],"URL":"https:\/\/doi.org\/10.1186\/s12959-026-00936-8","relation":{},"ISSN":["1477-9560"],"issn-type":[{"value":"1477-9560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,13]]},"assertion":[{"value":"6 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable for narrative review.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable for narrative review:","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"93"}}